Colgate
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Colgate 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CL
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments.
CEONoel R. Wallace
CEONoel R. Wallace
Employees34,000
Employees34,000
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1806
Founded1806
Employees34,000
Employees34,000
CL Key Statistics
Market cap63.03B
Market cap63.03B
Price-Earnings ratio21.92
Price-Earnings ratio21.92
Dividend yield2.62%
Dividend yield2.62%
Average volume5.88M
Average volume5.88M
High today$78.87
High today$78.87
Low today$77.92
Low today$77.92
Open price$78.41
Open price$78.41
Volume6.73M
Volume6.73M
52 Week high$102.61
52 Week high$102.61
52 Week low$77.91
52 Week low$77.91
CL News
Simply Wall St 7h
What Colgate-Palmolive's Dividend Aristocrat Status and Market Share Leadership Mean For ShareholdersColgate-Palmolive has been recognized as one of the 12 Best Dividend Aristocrat Stocks to invest in, emphasizing its global leadership in oral care with a 40.9%...
TipRanks 3d
Colgate-Palmolive assumed with a Neutral at Piper SandlerPiper Sandler assumed coverage of Colgate-Palmolive (CL) with a Neutral rating and $84 price target The company has strong brands and brand equity along with a...
TipRanks 5d
Colgate-Palmolive price target lowered to $82 from $87 at BarclaysBarclays analyst Lauren Lieberman lowered the firm’s price target on Colgate-Palmolive (CL) to $82 from $87 and keeps an Equal Weight rating on the shares. The...
Analyst ratings
55%
of 22 ratingsBuy
54.5%
Hold
40.9%
Sell
4.5%
More CL News
Nasdaq 5d
CL Quantitative Stock Analysis - Warren BuffettBelow is Validea's guru fundamental report for COLGATE-PALMOLIVE CO (CL). Of the 22 guru strategies we follow, CL rates highest using our Patient Investor model...
People also own
Based on the portfolios of people who own CL. This list is generated using Robinhood data, and it’s not a recommendation.